Induction of protective anti-tumor immunity by gene-modified dendritic cells

Journal of Immunotherapy

Volumn 21, Issue 1, 1998, Pages 41-47

  McArthur, James G ^a   Mulligan, Richard C ^a,b  

^a CELL GENESYS INC   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Antigen presentation; Dendritic cells; Gene therapy; Tumor immunotherapy

Indexed keywords

BETA GALACTOSIDASE;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE ACTIVATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOMODULATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; BETA-GALACTOSIDASE; DENDRITIC CELLS; FEMALE; GENETIC ENGINEERING; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VACCINES;

EID: 0031974235     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-199801000-00005     Document Type: Article

References (30)

1. Heslop H, Ng C, Li C, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med 1996;2:551-5.
2. Riddell S, Greenberg G. Principles for adoptive T cell therapy of human viral diseases. Annu Rev Immunol 1995;13:545-86.
3. Azuma M, Cayabyab M, Buck D, et al. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med 1992;175:353-60.
4. Harding F, McArthur J, Gross J, et al. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607-9.
5. McArthur J, Raulet D. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J Exp Med 1993;178:1645-53.
6. Linsley P, Brady W, Grosmaire L, et al. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991;173:721-30.
7. Parmiani G. Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cells. Immunol Today 1993;14:536-8.
8. Shimuzu J, Suda T, Yoshioka T, et al. Induction of tumor specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. J Immunol 1989;142:1053-9.
9. Grabbe S, Bruvers S, Gallo R, et al. Tumor antigen presentation by murine epidermal cells. J Immunol 1991;146:3656-61.
10. Flamand V, Sornasse T, Thielemans K, et al. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol 1994;24:605-10.
11. Guo Y, Wu M, Chen H, et al. Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science 1994;263: 518-20.
12. Paglia P, Chiodoni C, Rodolfo M, et al. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocyte against tumor antigen in vivo. J Exp Med 1996;183:317-22.
13. Celluzi C, Mayordomo J, Storkus W, et al. Peptide pulsed dendritic cells induce antigen-specific, CTL-mediated protective immunity. J Exp Med 1996;183:283-7.
14. Zitvogel L, Mayordomo J, et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cell, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 1996;183:87-97.
15. Mayordomo J, Zorina T, Storkus W, et al. Bone-marrow derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic anti-tumor immunity. Nature Med 1995;1: 1297-302.
16. Cohen P, Cohen P, Rosenberg S, et al. Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur J Immunol 1994;24:315-9.
17. Grabbe S, Beissert S, Schwarz T, et al. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy. Immunol Today 1995;16:117-20.
18. Progador A, Snyder D, Gilboa E. Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 1996;156: 2918-26.
19. Caux C, Liu Y, Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 1995; 16:2-6.
20. Steinman R. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
21. Inaba K, Pack M, Aya H, et al. Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 1992;175: 1157-67.
22. Freudenthal P, Steinman R. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 1990;87:7698-702.
23. Sallusto F, Lanzavecchio A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor α. J Exp Med 1994;179: 1109-18.
24. Reid C, Stackpoole A, Meager A, et al. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol 1992;149:2681-8.
25. Fidler I. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 1975;35:218-34.
26. Inaba K, Inaba M, Roman N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693-702.
27. Dwarki V, Bellon P, Nijjar T, et al. Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. Proc Natl Acad Sci USA 1995;92:1023-7.
28. Nonacs R, Humborg C, Tam J, et al. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J Exp Med 1992;176:519-29.
29. Oxenius A, Bachmann M, Mathis D, et al. Functional MHC class II loading by endogenously synthesized glycoprotein during viral infection. J Immunol 1997;158:5717-27.
30. Bernhard H, Disis M, Heimfeld S, et al. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res 1995;55:1099-104.